AQR Capital Management LLC Purchases 10,111 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

AQR Capital Management LLC boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.8% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 275,752 shares of the company’s stock after purchasing an additional 10,111 shares during the quarter. AQR Capital Management LLC owned about 0.06% of GE HealthCare Technologies worth $21,487,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in GEHC. 9258 Wealth Management LLC boosted its position in shares of GE HealthCare Technologies by 5.7% in the fourth quarter. 9258 Wealth Management LLC now owns 3,273 shares of the company’s stock valued at $253,000 after acquiring an additional 176 shares during the period. TD Asset Management Inc boosted its holdings in GE HealthCare Technologies by 5.4% in the 4th quarter. TD Asset Management Inc now owns 249,514 shares of the company’s stock valued at $19,292,000 after purchasing an additional 12,684 shares during the period. TFO Wealth Partners LLC grew its position in shares of GE HealthCare Technologies by 520.9% during the 4th quarter. TFO Wealth Partners LLC now owns 3,297 shares of the company’s stock worth $255,000 after purchasing an additional 2,766 shares in the last quarter. Bank of Nova Scotia increased its holdings in shares of GE HealthCare Technologies by 29.4% during the fourth quarter. Bank of Nova Scotia now owns 48,847 shares of the company’s stock worth $3,777,000 after purchasing an additional 11,103 shares during the period. Finally, California State Teachers Retirement System raised its position in shares of GE HealthCare Technologies by 3.3% in the fourth quarter. California State Teachers Retirement System now owns 667,316 shares of the company’s stock valued at $51,597,000 after buying an additional 21,461 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Insider Activity

In related news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the topic of a number of analyst reports. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research report on Wednesday, September 18th. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a report on Monday, September 9th. They set a “neutral” rating and a $90.00 target price on the stock. Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price objective for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. Finally, Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $94.08.

GE HealthCare Technologies Stock Up 2.0 %

Shares of NASDAQ:GEHC opened at $93.85 on Tuesday. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.55. The company has a market capitalization of $42.84 billion, a PE ratio of 27.44, a price-to-earnings-growth ratio of 3.40 and a beta of 1.17. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. The company has a fifty day moving average of $85.39 and a 200-day moving average of $83.26.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. The firm had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business’s quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the company earned $0.92 earnings per share. On average, equities analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.13%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.